BSE Live
Jan 02, 16:01Prev. Close
378.00
Open Price
378.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 02, 15:55Prev. Close
377.65
Open Price
380.90
Bid Price (Qty.)
379.85 (5010)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Panacea Biotec (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 11.97 | -10.34 | 19.94 | 22.32 | 10.66 | |
| Diluted EPS (Rs.) | 11.97 | -10.34 | 19.94 | 22.32 | 10.66 | |
| Cash EPS (Rs.) | 19.31 | -2.29 | 24.44 | 26.09 | 13.18 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 104.45 | 90.67 | 104.39 | 81.96 | 28.04 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 104.45 | 90.67 | 104.39 | 81.96 | 28.04 | |
| Dividend / Share(Rs.) | 0.25 | 0.00 | 1.00 | 1.00 | 1.00 | |
| Revenue from Operations/Share (Rs.) | 133.34 | 116.43 | 124.76 | 126.87 | 93.94 | |
| PBDIT/Share (Rs.) | 30.73 | -0.98 | 32.89 | 37.80 | 22.00 | |
| PBIT/Share (Rs.) | 23.42 | -9.01 | 28.42 | 34.07 | 19.57 | |
| PBT/Share (Rs.) | 17.70 | -13.82 | 26.68 | 31.76 | 17.50 | |
| Net Profit/Share (Rs.) | 11.97 | -10.34 | 19.94 | 22.32 | 10.66 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 23.04 | -0.84 | 26.36 | 29.79 | 23.41 | |
| PBIT Margin (%) | 17.56 | -7.73 | 22.77 | 26.85 | 20.82 | |
| PBT Margin (%) | 13.27 | -11.86 | 21.38 | 25.02 | 18.62 | |
| Net Profit Margin (%) | 8.97 | -8.87 | 15.98 | 17.59 | 11.34 | |
| Return on Networth / Equity (%) | 11.46 | -11.40 | 19.10 | 27.23 | 38.01 | |
| Return on Capital Employed (%) | 12.25 | -4.87 | 16.74 | 28.04 | 14.62 | |
| Return on Assets (%) | 4.71 | -4.00 | 10.33 | 14.09 | 5.97 | |
| Total Debt/Equity (X) | 1.01 | 1.16 | 0.57 | 0.40 | 3.66 | |
| Asset Turnover Ratio (%) | 52.52 | 45.04 | 64.66 | 80.13 | 52.64 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.82 | 1.56 | 3.51 | 2.51 | 3.04 | |
| Quick Ratio (X) | 0.73 | 0.65 | 2.15 | 1.65 | 2.33 | |
| Inventory Turnover Ratio (X) | 1.96 | 1.74 | 3.94 | 4.01 | 2.98 | |
| Dividend Payout Ratio (NP) (%) | 2.08 | 0.00 | 5.00 | 4.47 | 9.36 | |
| Dividend Payout Ratio (CP) (%) | 1.29 | 0.00 | 4.08 | 3.82 | 7.57 | |
| Earnings Retention Ratio (%) | 97.92 | 0.00 | 95.00 | 95.53 | 90.64 | |
| Cash Earnings Retention Ratio (%) | 98.71 | 0.00 | 95.92 | 96.18 | 92.43 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,144.32 | 1,035.52 | 2,498.75 | 2,789.21 | 2,436.36 | |
| EV/Net Operating Revenue (X) | 2.41 | 1.33 | 3.00 | 3.34 | 4.54 | |
| EV/EBITDA (X) | 10.44 | -157.71 | 11.38 | 11.22 | 19.37 | |
| MarketCap/Net Operating Revenue (X) | 1.66 | 0.51 | 2.69 | 3.27 | 4.10 | |
| Retention Ratios (%) | 97.91 | 0.00 | 94.99 | 95.52 | 90.63 | |
| Price/BV (X) | 2.11 | 0.65 | 3.22 | 5.07 | 13.73 | |
| Price/Net Operating Revenue | 1.66 | 0.51 | 2.69 | 3.27 | 4.10 | |
| Earnings Yield | 0.05 | -0.17 | 0.06 | 0.05 | 0.03 |
26.12.2025
16.12.2025
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y